Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Brain Tumor Pathology|November 26, 2021
Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomasTomohide Nishikawa, Reiko Watanabe, Yotaro Kitano, et al.Cancer Immunology Research|January 30, 2016
CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse BrainsSatoshi Shiina, Masasuke Ohno, Fumiharu Ohka, et al.Biorxiv : the Preprint Server for Biology|August 14, 2023
Glioma-neuronal circuit remodeling induces regional immunosuppressionTakahide Nejo, Saritha Krishna, Christian Jimenez, et al.Science and Technology of Advanced Materials|November 24, 2016
An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomasAkane Yamamichi, Toshihiro Kasama, Fumiharu Ohka, et al.Cancer Research|August 22, 2019
Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic GliomasFumiharu Ohka, Keiko Shinjo, Shoichi Deguchi, et al.Nature Communications|May 22, 2025
Glioma-neuronal circuit remodeling induces regional immunosuppressionTakahide Nejo, Saritha Krishna, Akane Yamamichi, et al.Scientific Reports|March 17, 2024
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.Biorxiv : the Preprint Server for Biology|November 14, 2023
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.Biorxiv : the Preprint Server for Biology|October 31, 2023
Tumor-wide RNA splicing aberrations generate immunogenic public neoantigensDarwin W Kwok, Nicholas O Stevers, Takahide Nejo, et al.Nature|February 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigensDarwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria, et al.Pageof 3